News | January 20, 2022
Strides Pharma and subsidiary Universal Corporation enters tie-up with Medicines Patent Pool
They will commercialize molnupiravir in the international markets
They will commercialize molnupiravir in the international markets
This is the company’s first partnership arrangement in China
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
The tele-heath market in India is expected to touch US $ 5.4 billion by 2025 and the adoption of tele-health has accelerated with the onset of Covid-19 in 2020. We caught up with Jeya Kumar, Founder and MD, RaphaCure, a prominent player in this segment and he outlined the opportunities that lie ahead for this segment
The stability is led by healthy demand in the domestic and emerging markets
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
BPZE1 is the most advanced next-generation pertussis vaccine currently in clinical development
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
Subscribe To Our Newsletter & Stay Updated
